Full Text View
Tabular View
No Study Results Posted
Related Studies
Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
This study has been completed.
Study NCT00541385   Information provided by Medicines for Malaria Venture

First Received on October 9, 2007.   Last Updated on January 21, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
Additional conditions recognized in this trial
Malaria, Falciparum
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
pyronaridine artesunate
arthemeter lumefantrine
Additional drug interventions recognized in this trial
Artemether-lumefantrine combination
Artesunate
Lumefantrine
Pyronaridine
More general drug interventions related to this trial
Amebicides
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Medicines for Malaria Venture
Shin Poong Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services